These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7591543)

  • 1. Information on marketed drugs for doctors and patients. Experience in six European countries.
    Brown P; Charlish P; Brazier H; Butterfield M
    Int J Technol Assess Health Care; 1995; 11(3):410-6. PubMed ID: 7591543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient information leaflets--helpful guidance or a source of confusion?
    Bjerrum L; Foged A
    Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical information in drug package inserts in India.
    Shivkar YM
    J Postgrad Med; 2009; 55(2):104-7. PubMed ID: 19550054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing information in 26 countries: a comparative study.
    Reggi V; Balocco-Mattavelli R; Bonati M; Breton I; Figueras A; Jambert E; Kopp C; Montane E; Rägo L; Rocchi F;
    Eur J Clin Pharmacol; 2003 Aug; 59(4):263-70. PubMed ID: 12759794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rules set for dissemination of off-label-use information.
    Miller JL
    Am J Health Syst Pharm; 1999 Feb; 56(3):204. PubMed ID: 10030500
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of pharmacoeconomics and outcomes research.
    Radensky P
    Value Health; 2001; 4(1):12-5. PubMed ID: 11704968
    [No Abstract]   [Full Text] [Related]  

  • 7. MedGuide: at last a long-sought opportunity for patient education about prescription drugs.
    Marwick C
    JAMA; 1997 Mar; 277(12):949-50. PubMed ID: 9091654
    [No Abstract]   [Full Text] [Related]  

  • 8. [Patient-oriented package inserts for drugs. Historical overview and current status].
    Van Haecht CH; Vander Stichele R; Bogaert M
    Arch Belg; 1989; 47(5-6):230-55. PubMed ID: 2700065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What drug labels don't tell you.
    Consum Rep; 2011 Aug; 76(8):10. PubMed ID: 21770080
    [No Abstract]   [Full Text] [Related]  

  • 10. Communicating with patients about their medications.
    Kessler DA
    N Engl J Med; 1991 Dec; 325(23):1650-2. PubMed ID: 1944456
    [No Abstract]   [Full Text] [Related]  

  • 11. [Unclear on dose adjustment in renal impairment].
    Asker-Hagelberg C; Rydberg D; Hentschke M; Holm L; Rosenborg S; Elinder CG
    Lakartidningen; 2013 May 22-28; 110(21):1030-2. PubMed ID: 23805768
    [No Abstract]   [Full Text] [Related]  

  • 12. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians prefer greater detail in the biosimilar label (SmPC) - Results of a survey across seven European countries.
    Hallersten A; Fürst W; Mezzasalma R
    Regul Toxicol Pharmacol; 2016 Jun; 77():275-81. PubMed ID: 27041395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs.
    Burkhart CG
    J Drugs Dermatol; 2005; 4(4):414-5. PubMed ID: 16004013
    [No Abstract]   [Full Text] [Related]  

  • 15. Educating patients about their medications: the potential and limitations of written drug information.
    Shrank WH; Avorn J
    Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotional literature: how do we critically appraise?
    Shetty VV; Karve AV
    J Postgrad Med; 2008; 54(3):217-21. PubMed ID: 18626173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Education responsibility, specialty and administration information from the legal viewpoint].
    Schreiber HL
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):653-7. PubMed ID: 9527463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stoning a dead bird: advertising limits on approved new drugs.
    Strobos J
    Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of German package inserts.
    Fuchs J; Hippius M; Schaefer M
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):8-13. PubMed ID: 16425965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveat emptor: Erroneous safety information about opioids in online drug-information compendia.
    Talwar SR; Randhawa AS; Dankiewicz EH; Crudele NT; Haddox JD
    J Opioid Manag; 2016; 12(4):281-8. PubMed ID: 27575829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.